GoldenGolden
Nextech Invest

Nextech Invest

A private equity and venture capital firm in Switzerland that focuses on precision therapies in oncology.

Nextech Invest Ltd is a private equity and venture capital firm in Switzerland that focuses on precision therapies in oncology. Founded 1998 in Zurich, Switzerland, it invests in early stage ventures, series B, series C, post-IPO equity, and series E rounds. Its portfolio companies include Circle Pharma, Silverback Therapeutics, Kinnate Biopharma, PMV Pharmaceuticals, and A2 Biotherapeutics. As of April 2020, Nextech Invest has made 33 investments. Their most recent investment was on March 17, 2020, when Circle Pharma raised $45M. Nextech Invest has had 17 exits, the most notable of which include Arvinas, Blueprint Medicines, and IDEAYA Biosciences. The company has raised a single venture fund, Oncology Fund IV. This fund was announced on July 21, 2016 and raised a total of $64M.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Autolus Therapeutics

Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.

Turning Point Therapeutics, Inc. is a clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies

A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases

Blueprint Medicines is a biotechnology company that is working to improve human health.

ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient's health--enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.

IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality

Neon Therapeutics is a biotechnology company developing immunotherapies for treating cancer.

Silverback Therapeutics is a Seattle-based biopharmaceutical company developing ImmunoTAC therapies targeting previously inaccessible disease pathways.

Kronos Bio is a Cambridge, Massachusetts-based therapeutics company working on research and development of therapies that modulate historically recalcitrant cancer targets.

Scorpion Therapeutics is a Boston-based company founded in 2020.

Cleave Therapeutics is a San Francisco-based biotechnology company focused on protein homeostasis and stress pathways in cancer and neurodegeneration.

A company focused on the discovery and development of small molecule drugs for the treatment of diseases

Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients.

REVOLUTION Medicines is a Redwood City, California-based company.

Black Diamond Therapeutics is a Biotechnology company.

Vividion Therapeutics is a San Diego-based company.

PMV Pharma is a Cranbury, New Jersey-based company.

18 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Alfred Scheidegger

CEO

Thilo Schroeder

Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Circle Pharma

Silverback Therapeutics

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.